European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD

BMC Psychiatry

Review

Ylva Ginsberg¹  Karin Foeken²  Veronique Gaillac³  Michael B Lensing⁴  Helmut Niederhofer⁵  Susanne Bejerot⁶  Dan Edvinsson⁷  Michael Fitzgerald⁸  Chantal Henry⁹  Carlos Nunes-Filipe^1,10  Iris Manor^1,11  John Fayyad^1,12  Herve Caci^1,13  Johanna Krause^1,14  Sandra JJ Kooij^1,15  Pieter J Carpentier^1,16  Miquel Casas-Brugué^1,17  Andrew Blackwell^1,18 

[1] Affektiva mottagningen, M 59, Psykiatri Sydväst, 141 86, Stockholm, Sweden;Centre des Consultations, Institut A Tzanck, Mougins, France;Clinique des Maladies Mentales et de l'Encéphale (CMME), Sainte Anne Hospital Paris, France;Department of Child Neurology, Oslo University Hospital, Ullevaal, Oslo, Norway;Department of Child Psychiatry, Regional Hospital of Bolzano, Via Guncina, Bolzano, Italy;Department of Clinical Neuroscience, Karolinksa Institutet, Section Psychiatry, St. Goran, Stockholm, Sweden;Department of Neuroscience/Psychiatri Ulleråker, MK 75, S-750 17, Uppsala, Sweden;Department of Psychiatry, Trinity College Dublin (TCD), Dublin 2, Ireland;Département de Psychiatrie Adulte, Unité Lescure, CH Charles Perrens, Bordeaux, France;Faculty of Medical Sciences, New University of Lisbon, Campo dos Mártires da Pátria, 1169-056, Lisboa, Portugal;Geha Mental Health Center, Petach-Tiqva, Sackler Faculty of Medicine, Tel-Aviv University, Israel;Institute of Development, Research, Advocacy and Applied Care (IDRAAC), Department of Psychiatry and Clinical Psychology, St George Hospital University Medical Centre, Balamand University, Beirut, Lebanon;Pediatric Department, Hôpitaux Pédiatriques CHU-Lenval, 06200, Nice, France;Private clinic for psychiatry and psychotherapy, 11a Schillerstrasse, Ottobrunn, Germany;PsyQ, psycho medische programma's, Department Adult ADHD, Carel Reinierszkade 197, Den Haag, The Netherlands;Reinier van Arkel Groep, Postbus 70058, 5201, DZ 's-Hertogenbosch, The Netherlands;Servicio de Psiquiatria, Hospital Universitari Vall d' Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain;University Department of Psychiatry, Addenbrookes Hospital, Cambridge, UK;

关键词: Attention Deficit Hyperactivity Disorder;    Methylphenidate;    Atomoxetine;    Modafinil;    Stimulant Medication;   

DOI  :  10.1186/1471-244X-10-67

 received in 2010-05-04, accepted in 2010-09-03,  发布年份 2010

来源: Springer

【 摘 要 】

BackgroundAttention deficit hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that persists into adulthood in the majority of cases. The evidence on persistence poses several difficulties for adult psychiatry considering the lack of expertise for diagnostic assessment, limited treatment options and patient facilities across Europe.MethodsThe European Network Adult ADHD, founded in 2003, aims to increase awareness of this disorder and improve knowledge and patient care for adults with ADHD across Europe. This Consensus Statement is one of the actions taken by the European Network Adult ADHD in order to support the clinician with research evidence and clinical experience from 18 European countries in which ADHD in adults is recognised and treated.ResultsBesides information on the genetics and neurobiology of ADHD, three major questions are addressed in this statement: (1) What is the clinical picture of ADHD in adults? (2) How can ADHD in adults be properly diagnosed? (3) How should ADHD in adults be effectively treated?ConclusionsADHD often presents as an impairing lifelong condition in adults, yet it is currently underdiagnosed and treated in many European countries, leading to ineffective treatment and higher costs of illness. Expertise in diagnostic assessment and treatment of ADHD in adults must increase in psychiatry. Instruments for screening and diagnosis of ADHD in adults are available and appropriate treatments exist, although more research is needed in this age group.

【 授权许可】

CC BY   
© Kooij et al; licensee BioMed Central Ltd. 2010